Ana Morales Benitez

The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer

P. Mazur, N. Flores, M. Person, 2023, Nature Communications.

Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities

Michael A. Beer, J. Ajani, P. Mazur, 2023, Gut.

Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis

P. Mazur, O. Gozani, Y. Couté, 2023, bioRxiv.

SMYD5 methylation of rpL40 links ribosomal output to gastric cancer.

J. Ajani, O. Gozani, I. Topisirovic, 2024, Nature.

Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis

O. Gozani, N. Reynoird, Ekaterina Bourova-Flin, 2024, Cell discovery.